FIBROGEN INC - COMMON
0,4247
29-ноября-24 13:45:00
15 мин. задержка
Акции
+0,0357
+9,18%
Сегодняшний диапазон
0,3813 - 0,4331
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
17 июн 2021 07:00:00 Источник Nasdaq GlobeNewswire
-
Pamrevlumab Included in Pancreatic Cancer Action Network’s Adaptive Clinical Trial Platform
16 июн 2021 08:00:01 Источник Nasdaq GlobeNewswire
-
FibroGen to Present at Upcoming Investor Conferences
27 май 2021 07:00:00 Источник Nasdaq GlobeNewswire
-
FibroGen Reports First Quarter 2021 Financial Results
10 май 2021 16:01:00 Источник Nasdaq GlobeNewswire
-
FibroGen to Report First Quarter 2021 Financial Results
03 май 2021 07:00:00 Источник Nasdaq GlobeNewswire
-
FibroGen to Present at Upcoming Investor Conference
28 апр 2021 07:00:00 Источник Nasdaq GlobeNewswire
-
15 апр 2021 07:00:00 Источник Nasdaq GlobeNewswire
-
12 апр 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
06 апр 2021 19:50:31 Источник Nasdaq GlobeNewswire
-
FibroGen Provides Additional Information on Roxadustat
06 апр 2021 16:01:00 Источник Nasdaq GlobeNewswire
-
16 мар 2021 07:00:00 Источник Nasdaq GlobeNewswire
-
FibroGen Provides Regulatory Update on Roxadustat
01 мар 2021 16:01:00 Источник Nasdaq GlobeNewswire
-
FibroGen Reports Fourth Quarter and Full Year 2020 Financial Results
01 мар 2021 16:01:00 Источник Nasdaq GlobeNewswire
-
FibroGen to Report Fourth Quarter and Full Year 2020 Financial Results
18 фев 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
FibroGen to Present at Upcoming Investor Conferences
12 фев 2021 07:00:00 Источник Nasdaq GlobeNewswire